Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
I binged all 24 Hallmark Christmas movies in less than 30 days. I emerged a changed man. - 2New COVID-19 variant 'Cicada' is spreading. What to know about BA.3.2.
- 3The most effective method to Pick the Best Wellbeing Highlights for Seniors in SUVs
- 4Trump said affordability is a ‘hoax’ in his Pennsylvania speech. What do the latest numbers show?
- 5German economic institutes cut forecast in half over Iran war
- China Just Got A Lot Closer To Its First-Ever Manned Moon Landing
- Google's proposed data center in orbit will face issues with space debris in an already crowded orbit
- How will the universe end?
- South Carolina confirms 124 new measles cases as outbreak on the Arizona-Utah line grows
- The Best Internet Mastering Stages for Expertise Improvement
- Brazil approves law strengthening protective measures for female victims of gender-based violence
- Foods with healthy-sounding buzzwords could be hiding added sugar in plain sight
- With more Moon missions on the horizon, avoiding crowding and collisions will be a growing challenge
- Army commander convicted of Guinea stadium massacre dies in prison
